Inflammation is defined as a tissue directed response to noxious and injurious external and internal stimuli, which is predominantly mediated by arachidonic acid metabolites. In the early 1990s two groups independently detected the existence of two cyclooxygenases COX-1 and COX-2[@CIT1]. While the inhibition of COX-2 activity led to antiinflammatory activity, COX-1 inhibition led to ulcerogenic activity. Non steroidal antiinflammatory drugs are a non homogeneous family of pharmacologically active compounds used in the treatment of acute and chronic inflammation, pain and fever. Review of experimental data reveals that subtle changes in the binding site of COX-2 might occur to adopt its structure to the inhibitor[@CIT2][@CIT3]. This might be the reason for many diverse group of compounds reported to have antiinflammatory activity[@CIT4]--[@CIT7]. The survey of newer CoX-2 inhibitors shows that the presence of sulphanamide and biphenyl groups which might be essential for COX-2 activity. Substituted thiazolidin-4-one derivatives have shown promising cyclooxygenase and 5-lipoxygenase inhibiting properties and used as topical antiinflammatory agents for inflamed conditions of skin. Moreover, the inflammation is a general condition associated with infection and sulphonamide group appears to be essential for antiinflammatory activity. Hence various derivatives of thiazolidin-4-ones synthesized were evaluated for their antiinflammatory, analgesic, antipyretic and cyclooxygenase inhibitory activities.

MATERIALS AND METHODS {#sec1-1}
=====================

Wistar rats of either sex weighing 150-200 g were used. Animals were housed in groups of six per cage at a temperature of 25±1° and relative humidity of 45±5%. A 12:12 hour light:dark cycle was followed during the experiments. Animals had free access to food and water, however, food was withdrawn six hours before and during the experiments. The animals were obtained from the Central Animal House of J. N. Medical College, Belgaum (India). The Institutional Animal Ethical Committee approved the protocol of the study.

The drugs synthesized in the Chemistry laboratory of K. L. E. S\'s College of pharmacy, Belgaum, were used. The drugs were coded as B~1~ to B~8~ (thiazolidine-4-one compounds) and B~9~ to B~11~ (Spiro derivatives of thiazolodine-4-one) [Table 1](#T0001){ref-type="table"}. The standard drug nimesulide was obtained from Lincoln pharmaceuticals Ltd. Ahamedabad.

###### 

SHOWING VARIOUS SUBSTITUTIONS IN THIZOLIDINONE MOIETY

  Compound code   R (R)   R' (R1)   R" (R2)
  --------------- ------- --------- ---------
  B~1~            H       H         H
  B~2~            H       OCH~3~    H
  B~3~            CH~3~   Cl        H
  B~4~            CH~3~   OCH~3~    H
  B~5~            H       OCH~3~    OH
  B~6~            H       Cl        H
  B~7~            CH~3~   NO2       H
  B~8~            H       F         H
  B~9~            H       H         H
  B~10~           H       OCH~3~    H
  B~11~           CH~3~   OCH~3~    H

Toxicity studies: {#sec2-1}
-----------------

The acute toxicity study was done as per the OECD guidelines (407). The compounds were administered orally in different doses, where 24 h toxicity was recorded to identify the toxic doses. The doses of the test compounds were then fixed on the basis of their acute toxicity as 50 mg/kg and 100 mg/kg for evaluation. The antiinflammatory activity was studied using acute and chronic models.

Carrageenan-induced paw edema[@CIT8]: {#sec2-2}
-------------------------------------

All the test compounds namely B~1~ to B~11~ were administered in two doses 50 mg/kg and 100 mg/kg body weight based upon their acute toxicity studies and nimesulide 50 mg/kg b.w. was used as standard. The test compounds were administered orally to the rats suspended in 0.5% carboxymethyl cellulose (CMC). The control animals received 0.5% CMC. Thirty minutes after drug administration, 0.1ml of 1% carrageenan (Sigma) in normal saline solution was injected into the subplantar region of one of the hind paws. The paw edema volume was recorded using a plethysmometer (UGO Basile, Italy) at different time intervals.

Xylol-induced mouse ear edema[@CIT9]: {#sec2-3}
-------------------------------------

The test compounds, standard and vehicle as mentioned above were administered orally to the mice. Thirty minutes after administration, inflammation was induced by a topical application of 2% xylol (20μl) to the right ear of each mouse. The left ear was kept as control. The positive control group received only 0.5 ml of 1% CMC. After 30 minutes of xylol application, the animals were killed by cervical dislocation. A 6 mm section of ear disc was obtained by punching the ear and then weighed. The inflammation induced by xylol was assessed by the change in the weight of ear punch of treated groups over control and this is called the edema index.

Cotton pellet-induced granuloma in rats[@CIT10]: {#sec2-4}
------------------------------------------------

Two sterilized cotton pellets, each weighing 10mg were implanted subcutaneously into axilla in anaesthetized rats. After treatment with test compounds, standard and vehicle for 10 days the rats were sacrificed. They were dissected to take out granuloma tissue and dried at 60° overnight to determine the dry weight. Results were expressed as mg/100 g.

Writhing test[@CIT11]: {#sec2-5}
----------------------

Acetic acid-induced writhing model was employed to evaluate the analgesic activity. The test compounds, standard and vehicle were administered orally to the mice and 30 min later 0.6% acetic acid solution (10 ml/kg.) was injected intraperitoneally. Nimesulide (50 mg/kg) was used as standard. The number of writhes induced in each mouse was observed for 10 min period starting 10 min after injection of acetic acid. The analgesic activity was expressed in terms of percentage inhibition of writhes produced by acetic acid.

Rat caudal immersion method[@CIT12]: {#sec2-6}
------------------------------------

The test compounds, standard and vehicle as given above were administered orally. The reaction time for withdrawal of tail was recorded after 60 min from the administration of test compounds. It was determined by immersing the tail up to the caudal portion (5 cm from the tip) in hot water (55±0.5°) and by noting the time taken to withdraw the tail clearly out of water. Observations were made at an interval of 30, 60, and 180 min after the initial reading.

Antipyretic activity: {#sec2-7}
---------------------

Yeast induced pyrexia was used to evaluate the antipyretic activity of the test compounds. The body temperature of each rat was recorded by measuring the rectal temperature at predetermined time intervals. Fever was induced by injecting 15% suspension of Brewer\'s yeast (*Saccharomyces cerevisiae*) following a standard method[@CIT12]. The rats were allowed to remain quiet in the cage for sometime. A thermister probe was inserted 3-4 cm deep into the rectum after fastening the tail to record the basal rectal temperature. The animals were then given a subcutaneous injection of 10 ml/kg of 15%w/v Brewer\'s yeast suspended in 0.5% w/v CMC solution and the animals were returned to their housing cages. Nineteen hours after yeast injection, the rats were again restrained in individual cages to record their rectal temperature. Immediately the test compounds and standard were administered orally at their respective doses. Rectal temperature of all the rats was recorded at 19 h immediately before the administration of test compounds, vehicle and paracetamol (50 mg/kg.) and again at 1hour intervals upto 3hours after the administration.

Cyclooxygenase inhibition activity: {#sec2-8}
-----------------------------------

The colorimetric COX (ovine) Inhibitor Screening Assay utilizes the peroxidase component of cyclooxygenase. The peroxidase activity is assayed colorimetrically by monitoring the appearance of oxidized N,N,N,N-Tetramethyl-p-phenylenediamine (TMPD) at 590 nm. The estimation of COX-1 and COX-2 enzyme inhibitor activity was done using the kit supplied by Cayman Chemical (USA). The kit contained Assay buffer (10X), Heme, COX-1(Ovine), COX-2(Ovine), Arachidonic acid, Potassium hydroxide, Colorimetric substrate, 96 well plate.

Statistical Analysis: {#sec2-9}
---------------------

The Statistical analysis was performed by using One Way ANOVA followed by Dunnet\'s Test. and the P\< 0.01 was taken as significant.

RESULTS AND DISCUSSION {#sec1-2}
======================

The effect of thiazolidin-4-one derivatives on carrageenan-induced paw edema and cotton pellet-induced granuloma in rats are mentioned in Table [2](#T0002){ref-type="table"} and [3](#T0003){ref-type="table"}. All the eleven compounds B~1~ to B~11~ showed significant inhibition of edema and granuloma dry weight at both the doses tested (50 mg/kg and 100 mg/kg) in a dose-dependant manner. The maximum inhibition was observed at 3^rd^ h. The maximum inhibition of edema and reduction in dry weight was produced by compounds B~1~, B~3~, B~4~, B~6~, B~8~, B~10~, and B~11~ as compared to standard nimesulide. The results of effect of thiazolidin-4-one derivatives on xylol-induced ear edema in mice are given in [Table 4](#T0004){ref-type="table"} and analgesic activity of thiazolidin-4-ones in acetic acid induced writhing in mice and rat caudal immersion are mentioned in [Table 5](#T0005){ref-type="table"}. All the test compounds also showed significant inhibition of edema in xylol induced mouse ear edema; however, it was less as compared to standard nimesulide. In acetic acid-induced writhing all the test compounds showed significant analgesic activity equal to standard nimesulide, however, in caudal immersion test none of the compounds showed any analgesic activity. In yeast induced pyrexia test compounds B~1~, B~2~, B~5~, B~6~, B~7~, B~8~ and B~11~ showed significant inhibition of pyrexia at higher dose of 100 mg/kg as compared to B~3~, B~4~, B~9~ and B~10~ ([Table 6](#T0006){ref-type="table"}). In *in vitro* COX-1 and COX-2 enzyme inhibition assay, the test compounds B~1~, B~2~, B~5~, B~6~ and B~8~ showed maximum inhibition of COX-2 enzyme activity than the other test compounds and comparable to nimesulide. However, all the test compounds and standard did not inhibit the COX-1 enzyme activity ([Table 7](#T0007){ref-type="table"}).

###### 

EFFECT OF THIAZOLIDINONE DERIVATIVES ON CARRAGEENAN-INDUCED PAW EDEMA

  Compound code   Dose (mg/kg)   Mean paw volume at different time intervals (ml)   Percentage inhibition of edema volume (ml)              
  --------------- -------------- -------------------------------------------------- ------------------------------------------------ ------ ------
  Control         50             5.85±0.044                                         6.82±0.018                                       0.0    0.0
  Nimesulide      50             4.97±0.014[\*\*](#T000F1){ref-type="table-fn"}     3.84±0.012[\*\*](#T000F1){ref-type="table-fn"}   15.1   43.7
  B~1~            50             4.68±0.046[\*\*](#T000F1){ref-type="table-fn"}     5.46±0.064[\*\*](#T000F1){ref-type="table-fn"}   20.0   20.0
                  100            4.72±0.064[\*\*](#T000F1){ref-type="table-fn"}     4.71±0.056[\*\*](#T000F1){ref-type="table-fn"}   19.4   31.0
  B~2~            50             5.12±0.079[\*\*](#T000F1){ref-type="table-fn"}     4.02±0.040[\*\*](#T000F1){ref-type="table-fn"}   12.5   41.1
                  100            4.74±0.027[\*\*](#T000F1){ref-type="table-fn"}     4.06±0.054[\*\*](#T000F1){ref-type="table-fn"}   18.9   40.5
  B~3~            50             5.17±0.067[\*\*](#T000F1){ref-type="table-fn"}     4.34±0.061[\*\*](#T000F1){ref-type="table-fn"}   11.7   36.4
                  100            5.09±0.039[\*\*](#T000F1){ref-type="table-fn"}     3.92±0.025[\*\*](#T000F1){ref-type="table-fn"}   13.0   42.6
  B~4~            50             4.89±0.033[\*\*](#T000F1){ref-type="table-fn"}     4.19±0.061[\*\*](#T000F1){ref-type="table-fn"}   16.4   38.6
                  100            4.73±0.024[\*\*](#T000F1){ref-type="table-fn"}     4.23±0.021[\*\*](#T000F1){ref-type="table-fn"}   19.1   37.9
  B~5~            50             5.04±0.048[\*\*](#T000F1){ref-type="table-fn"}     4.39±0.037[\*\*](#T000F1){ref-type="table-fn"}   13.9   35.6
                  100            4.90±0.039[\*\*](#T000F1){ref-type="table-fn"}     4.08±0.056[\*\*](#T000F1){ref-type="table-fn"}   16.2   40.2
  B~6~            50             5.09±0.039[\*\*](#T000F1){ref-type="table-fn"}     4.29±0.032[\*\*](#T000F1){ref-type="table-fn"}   12.9   37.0
                  100            4.94±0.040[\*\*](#T000F1){ref-type="table-fn"}     4.04±0.037[\*\*](#T000F1){ref-type="table-fn"}   15.5   40.8
  B~7~            50             4.97±0.056[\*\*](#T000F1){ref-type="table-fn"}     4.29±0.032[\*\*](#T000F1){ref-type="table-fn"}   15.0   37.0
                  100            4.88±0.030[\*\*](#T000F1){ref-type="table-fn"}     4.04±0.040[\*\*](#T000F1){ref-type="table-fn"}   16.6   40.8
  B~8~            50             4.74±0.045[\*\*](#T000F1){ref-type="table-fn"}     4.56±0.033[\*\*](#T000F1){ref-type="table-fn"}   19.0   33.2
                  100            4.90±0.030[\*\*](#T000F1){ref-type="table-fn"}     3.61±0.072[\*\*](#T000F1){ref-type="table-fn"}   16.3   47.1
  B~9~            50             5.36±0.108[\*\*](#T000F1){ref-type="table-fn"}     4.21±0.031[\*\*](#T000F1){ref-type="table-fn"}   08.4   38.3
                  100            4.63±0.045[\*\*](#T000F1){ref-type="table-fn"}     4.08±0.015[\*\*](#T000F1){ref-type="table-fn"}   20.9   40.2
  B~10~           50             5.16±0.048[\*\*](#T000F1){ref-type="table-fn"}     4.77±0.052[\*\*](#T000F1){ref-type="table-fn"}   11.8   30.1
                  100            5.02±0.091[\*\*](#T000F1){ref-type="table-fn"}     4.50±0.049[\*\*](#T000F1){ref-type="table-fn"}   14.2   34.1
  B~11~           50             5.24±0.108[\*\*](#T000F1){ref-type="table-fn"}     4.46±0.091[\*\*](#T000F1){ref-type="table-fn"}   10.5   34.7
                  100            5.02±0.027[\*\*](#T000F1){ref-type="table-fn"}     4.27±0.031[\*\*](#T000F1){ref-type="table-fn"}   14.2   37.4

N=6, Values are Mean±SEM

*P*\<0.01(significant), values are compared with control group

###### 

EFFECT OF THIAZOLIDINONES ON COTTON PELLET INDUCED GRANULOMA IN RATS

  Compound code   Dose (mg/kg)   Dry granuloma tissue weight (mg)                   Percentage inhibition
  --------------- -------------- -------------------------------------------------- -----------------------
  Control         50             45.70±1.133                                        0.0
  Nimesulide      50             25.82±1.398[\*\*](#T000F2){ref-type="table-fn"}    43.6
  B~1~            50             29.53±1.062[\*\*](#T000F2){ref-type="table-fn"}    35.4
                  100            27.56±1.133[\*\*](#T000F2){ref-type="table-fn"}    39.7
  B~2~            50             30.18±1.573[\*\*](#T000F2){ref-type="table-fn"}    34.0
                  100            28.61±2.461[\*\*](#T000F2){ref-type="table-fn"}    32.8
  B~3~            50             30.74±1.141[\*\*](#T000F2){ref-type="table-fn"}    37.4
                  100            28.00±1.716[\*\*](#T000F2){ref-type="table-fn"}    38.8
  B~4~            50             29.68±2.008[\*\*](#T000F2){ref-type="table-fn"}    35.1
                  100            26.30±1.322[\*\*](#T000F2){ref-type="table-fn"}    42.5
  B~5~            50             31.51±1.171[\*\*](#T000F2){ref-type="table-fn"}    31.1
                  100            28.58±0.9896[\*\*](#T000F2){ref-type="table-fn"}   37.5
  B~6~            50             29.67±2.626[\*\*](#T000F2){ref-type="table-fn"}    35.1
                  100            26.72±1.435[\*\*](#T000F2){ref-type="table-fn"}    41.5
  B~7~            50             32.84±1.644[\*\*](#T000F2){ref-type="table-fn"}    28.2
                  100            29.68±1.071[\*\*](#T000F2){ref-type="table-fn"}    35.1
  B~8~            50             29.98±1.583[\*\*](#T000F2){ref-type="table-fn"}    34.4
                  100            27.72±0.9156[\*\*](#T000F2){ref-type="table-fn"}   39.4
  B~9~            50             29.85±1.612[\*\*](#T000F2){ref-type="table-fn"}    34.7
                  100            28.76±0.6516[\*\*](#T000F2){ref-type="table-fn"}   37.1
  B~10~           50             31.46±2.302[\*\*](#T000F2){ref-type="table-fn"}    31.2
                  100            27.88±1.261[\*\*](#T000F2){ref-type="table-fn"}    39.0
  B~11~           50             32.19±1.249[\*\*](#T000F2){ref-type="table-fn"}    29.6
                  100            27.86±1.035[\*\*](#T000F2){ref-type="table-fn"}    39.1

N=6, Values are Mean±SEM

*P*\<0.01 (significant), values are compared with control group

###### 

EFFECT OF THIAZOLIDINONE DERIVATIVES ON XYLOL-INDUCED EAR EDEMA IN MICE

  Compound code   Dose (mg/kg)   Weight of the ear (mg)                           Percentage inhibition
  --------------- -------------- ------------------------------------------------ -----------------------
  Control         50             8.68±0.414                                       0.0
  Nimesulide      50             2.82±0.188[\*\*](#T000F3){ref-type="table-fn"}   67.51
  B~1~            50             7.06±0.294[\*\*](#T000F3){ref-type="table-fn"}   28.54
                  100            4.96±0.335[\*\*](#T000F3){ref-type="table-fn"}   49.79
  B~2~            50             7.12±0.343[\*\*](#T000F3){ref-type="table-fn"}   27.93
                  100            4.94±0.329[\*\*](#T000F3){ref-type="table-fn"}   50.00
  B~3~            50             6.88±0.333[\*\*](#T000F3){ref-type="table-fn"}   30.36
                  100            4.14±0.136[\*\*](#T000F3){ref-type="table-fn"}   58.09
  B~4~            50             6.98±0.427[\*\*](#T000F3){ref-type="table-fn"}   29.35
                  100            4.32±0.399[\*\*](#T000F3){ref-type="table-fn"}   56.27
  B~5~            50             6.98±0.379[\*\*](#T000F3){ref-type="table-fn"}   29.35
                  100            4.30±0.270[\*\*](#T000F3){ref-type="table-fn"}   56.47
  B~6~            50             7.34±0.405[\*\*](#T000F3){ref-type="table-fn"}   25.70
                  100            4.84±0.294[\*\*](#T000F3){ref-type="table-fn"}   51.01
  B~7~            50             6.56±0.411[\*\*](#T000F3){ref-type="table-fn"}   33.60
                  100            4.24±0.188[\*\*](#T000F3){ref-type="table-fn"}   57.08
  B~8~            50             6.40±0.148[\*\*](#T000F3){ref-type="table-fn"}   35.22
                  100            4.42±0.229[\*\*](#T000F3){ref-type="table-fn"}   55.26
  B~9~            50             6.08±0.352[\*\*](#T000F3){ref-type="table-fn"}   29.95
                  100            3.98±0.086[\*\*](#T000F3){ref-type="table-fn"}   54.14
  B~10~           50             6.02±0.182[\*\*](#T000F3){ref-type="table-fn"}   30.64
                  100            3.40±0.148[\*\*](#T000F3){ref-type="table-fn"}   60.89
  B~11~           50             6.38±0.407[\*\*](#T000F3){ref-type="table-fn"}   26.49
                  100            4.24±0.266[\*\*](#T000F3){ref-type="table-fn"}   51.15

N=6, Values are Mean±SEM

*P*\<0.01 (significant), values are compared with control group

###### 

ANALGESIC ACTIVITY OF THIAZOLIDINONES IN ACETIC ACID-INDUCED WRITHING IN MICE AND RAT CAUDAL IMMERSION

  Compound code   Dose (mg/kg)   Writhing response                                Percentage inhibition   Caudal immersion reaction time (In sec.)
  --------------- -------------- ------------------------------------------------ ----------------------- ------------------------------------------
  Control         50             36.00±0.70                                       0.0                     1.05±0.022
  Nimesulide      50             14.50±0.64[\*\*](#T000F4){ref-type="table-fn"}   59.8                    4.05±0.010
  B~1~            50             22.50±0.86[\*\*](#T000F4){ref-type="table-fn"}   37.5                    1.90±0.02
                  100            20.00±1.58[\*\*](#T000F4){ref-type="table-fn"}   44.5                    1.85±0.08
  B~2~            50             20.00±1.87[\*\*](#T000F4){ref-type="table-fn"}   44.5                    1.70±0.04
                  100            16.75±1.31[\*\*](#T000F4){ref-type="table-fn"}   53.5                    1.72±0.02
  B~3~            50             20.25±1.43[\*\*](#T000F4){ref-type="table-fn"}   43.8                    1.60±0.05
                  100            16.50±0.86[\*\*](#T000F4){ref-type="table-fn"}   54.2                    1.70±0.06
  B~4~            50             18.75±0.75[\*\*](#T000F4){ref-type="table-fn"}   48.0                    2.02±0.04
                  100            14.25±0.94[\*\*](#T000F4){ref-type="table-fn"}   60.5                    2.08±0.02
  B~5~            50             20.00±1.08[\*\*](#T000F4){ref-type="table-fn"}   44.5                    1.90±0.12
                  100            16.50±1.04[\*\*](#T000F4){ref-type="table-fn"}   54.2                    1.80±0.14
  B~6~            50             25.25±1.75[\*\*](#T000F4){ref-type="table-fn"}   29.9                    2.10±0.08
                  100            24.00±0.70[\*\*](#T000F4){ref-type="table-fn"}   33.4                    2.14±0.06
  B~7~            50             17.75±2.68[\*\*](#T000F4){ref-type="table-fn"}   50.7                    2.14±0.06
                  100            13.75±0.85[\*\*](#T000F4){ref-type="table-fn"}   61.9                    1.98±0.02
  B~8~            50             18.50±1.19[\*\*](#T000F4){ref-type="table-fn"}   48.7                    1.80±0.12
                  100            15.00±1.47[\*\*](#T000F4){ref-type="table-fn"}   58.4                    2.06±0.18
  B~9~            50             18.00±0.91[\*\*](#T000F4){ref-type="table-fn"}   50.0                    1.52±0.06
                  100            15.50±1.19[\*\*](#T000F4){ref-type="table-fn"}   57.0                    1.40±0.02
  B~10~           50             18.50±1.19[\*\*](#T000F4){ref-type="table-fn"}   48.7                    1.62±0.06
                  100            14.00±0.70[\*\*](#T000F4){ref-type="table-fn"}   61.2                    1.52±0.04
  B~11~           50             17.75±1.03[\*\*](#T000F4){ref-type="table-fn"}   50.7                    1.42±0.02
                  100            15.00±0.70[\*\*](#T000F4){ref-type="table-fn"}   58.4                    1.38±0.04

N=6, Values are Mean±SEM

*P*\<0.01 (significant), values are compared with control group

###### 

EFFECT OF THIAZOLIDINONE DERIVATIVES ON YEAST-INDUCED PYREXIA

  Compound code   Dose (mg/kg)   Yeast induced Pyrexia (Temp. in °C)                                                                                                     
  --------------- -------------- ------------------------------------- ------------------------------------------------ ------------------------------------------------ ------------------------------------------------
  Control         50             37.66±0.26                            37.48±0.22                                       37.24±0.15                                       36.66±0.18
  Nimesulide      50             37.46±0.12                            36.94±0.06[\*](#T000F6){ref-type="table-fn"}     36.66±0.07[\*](#T000F6){ref-type="table-fn"}     35.44±0.11[\*\*](#T000F5){ref-type="table-fn"}
  B~1~            50             36.96±0.08                            36.68±0.09[\*\*](#T000F5){ref-type="table-fn"}   36.42±0.08[\*\*](#T000F5){ref-type="table-fn"}   36.02±0.04[\*\*](#T000F5){ref-type="table-fn"}
                  100            37.00±0.13                            36.72±0.06[\*\*](#T000F5){ref-type="table-fn"}   36.32±0.05[\*\*](#T000F5){ref-type="table-fn"}   35.60±0.04[\*\*](#T000F5){ref-type="table-fn"}
  B~2~            50             37.10±0.12                            36.80±0.13[\*](#T000F6){ref-type="table-fn"}     36.60±0.10[\*\*](#T000F5){ref-type="table-fn"}   36.44±0.06
                  100            37.08±0.10                            36.72±0.08[\*\*](#T000F5){ref-type="table-fn"}   36.48±0.08[\*\*](#T000F5){ref-type="table-fn"}   35.46±0.14[\*\*](#T000F5){ref-type="table-fn"}
  B~3~            50             37.26±0.16                            36.90±0.14[\*](#T000F6){ref-type="table-fn"}     36.60±0.20[\*\*](#T000F5){ref-type="table-fn"}   36.32±0.12
                  100            36.96±0.08                            36.66±0.06[\*\*](#T000F5){ref-type="table-fn"}   36.22±0.06[\*\*](#T000F5){ref-type="table-fn"}   35.64±0.05[\*\*](#T000F5){ref-type="table-fn"}
  B~4~            50             37.18±0.15                            36.98±0.16                                       36.64±0.07[\*](#T000F6){ref-type="table-fn"}     36.28±0.04
                  100            37.32±0.16                            36.98±0.11[\*](#T000F6){ref-type="table-fn"}     36.62±0.05[\*\*](#T000F5){ref-type="table-fn"}   35.88±0.09[\*\*](#T000F5){ref-type="table-fn"}
  B~5~            50             37.06±0.16                            36.78±0.11[\*](#T000F6){ref-type="table-fn"}     36.64±0.15[\*](#T000F6){ref-type="table-fn"}     36.34±0.06
                  100            37.24±0.15                            36.88±0.13[\*\*](#T000F5){ref-type="table-fn"}   36.64±0.12[\*\*](#T000F5){ref-type="table-fn"}   35.74±0.09[\*\*](#T000F5){ref-type="table-fn"}
  B~6~            50             37.48±0.24                            36.96±0.21                                       36.56±0.18[\*\*](#T000F5){ref-type="table-fn"}   36.22±0.10[\*](#T000F6){ref-type="table-fn"}
                  100            37.18±0.11                            36.72±0.15[\*\*](#T000F5){ref-type="table-fn"}   36.40±0.13[\*\*](#T000F5){ref-type="table-fn"}   35.60±0.11[\*\*](#T000F5){ref-type="table-fn"}
  B~7~            50             37.22±0.18                            36.76±0.08[\*\*](#T000F5){ref-type="table-fn"}   36.48±0.03[\*\*](#T000F5){ref-type="table-fn"}   36.18±0.06[\*\*](#T000F5){ref-type="table-fn"}
                  100            37.02±0.08                            36.46±0.09                                       36.38±0.06[\*\*](#T000F5){ref-type="table-fn"}   35.56±0.08[\*\*](#T000F5){ref-type="table-fn"}
  B~8~            50             37.18±0.18                            36.80±0.10[\*](#T000F6){ref-type="table-fn"}     36.42±0.11[\*\*](#T000F5){ref-type="table-fn"}   36.20±0.06[\*](#T000F6){ref-type="table-fn"}
                  100            37.14±0.12                            36.72±0.05[\*\*](#T000F5){ref-type="table-fn"}   36.30±0.10[\*\*](#T000F5){ref-type="table-fn"}   35.56±0.12[\*\*](#T000F5){ref-type="table-fn"}
  B~9~            50             37.14±0.12                            36.82±0.09[\*\*](#T000F5){ref-type="table-fn"}   36.52±0.12[\*\*](#T000F5){ref-type="table-fn"}   36.10±0.08[\*\*](#T000F5){ref-type="table-fn"}
                  100            37.24±0.11                            36.86±0.08[\*](#T000F6){ref-type="table-fn"}     36.46±0.13[\*\*](#T000F5){ref-type="table-fn"}   35.78±0.18[\*\*](#T000F5){ref-type="table-fn"}
  B~10~           50             37.64±0.08                            37.04±0.06                                       36.54±0.06[\*\*](#T000F5){ref-type="table-fn"}   36.10±0.06[\*](#T000F6){ref-type="table-fn"}
                  100            36.94±0.06                            36.62±0.11[\*\*](#T000F5){ref-type="table-fn"}   36.26±0.10[\*\*](#T000F5){ref-type="table-fn"}   35.44±0.07[\*\*](#T000F5){ref-type="table-fn"}
  B~11~           50             37.32±0.12                            36.82±0.07[\*\*](#T000F5){ref-type="table-fn"}   36.58±0.03[\*\*](#T000F5){ref-type="table-fn"}   35.98±0.11[\*](#T000F6){ref-type="table-fn"}
                  100            37.10±0.10                            36.62±0.15[\*\*](#T000F5){ref-type="table-fn"}   36.20±0.07[\*\*](#T000F5){ref-type="table-fn"}   35.58±0.09[\*\*](#T000F5){ref-type="table-fn"}

N=6, Values are Mean±SEM

*P*\<0.01(significant)

*P*\<0.05(significant) values are compared with control group

###### 

EFFECT OF THIAZOLIDINONE DERIVATIVES ON COX-1 AND COX-2 ENZYME INHIBITORY ACTIVITY

  Compound code                 Drug in μg/ml   Percentage Inhibition[\*](#T000F7){ref-type="table-fn"}   
  ----------------------------- --------------- --------------------------------------------------------- --------
  Background wells              \-              \-                                                        \-
  100% initial activity wells   \-              \-                                                        \-
  B~1~                          10              08.176                                                    44.391
  B~2~                          10              13.522                                                    49.880
  B~3~                          10              12.839                                                    41.050
  B~4~                          10              07.232                                                    42.959
  B~5~                          10              01.759                                                    46.778
  B~6~                          10              01.194                                                    44.391
  B~7~                          10              02.974                                                    38.663
  B~8~                          10              05.660                                                    43.198
  B~9~                          10              01.542                                                    11.697
  B~10~                         10              02.349                                                    09.983
  B~11~                         10              02.843                                                    15.295

Average of 3 readings

In the present study, eleven derivatives of thiazolidine-4-ones synthesized (B~1~ to B~11~ ) from sulphanilamide, a well known antibacterial agent were evaluated for antiinflammatory, analgesic and antipyretic activities using various models. In all these compounds the free amine group is replaced by thiazolidine-4-one with functional group substitution at R, R~1~ and R~2~ positions ([fig. 1](#F0001){ref-type="fig"}). All the test compounds showed significant antiinflammatory, analgesic, antipyretic and COX-2 enzyme inhibition activity very much similar to nimesulide. However, substitution of functional groups at R-H, R~1~-OCH~3~ and R~2~-H in B~2~, R-H, R~1~-OCH~3~ and R~2~-OH in B~5~, R-H, R~1~-Cl and R~2~-H in B~6~, R-CH~3~, R~1~-NO~2~ and R~2~-H in B~7~, R-H, R~1~-F and R~2~-H in B~8~ showed significantly higher activity as compared to B~1~ where there is no substitution at both R and R~2~ positions. However, compounds B~3~ and B~4~ even though had substitution R-CH~3~, R~1~-Cl and R~2~-H in B~3~ and R-CH~3~, R~1~-OCH~3~ and R~2~-H in B~4~, did not show higher activity. Similarly in the spiro substituted compounds the substitution of functional groups R-CH~3~, R~1~-OCH~3~ and R~2~-H in B~11~ lead to an increased activity as compared to non-substituted B~9~ and B~10~ compounds~.~ In general all the spiro substituted derivatives showed less activity, which may be attributed to the introduction of spiro group in thiazolidine-4-one that may interfere in the binding of test compounds to the enzyme. This shows that any substitution at the 5-position in the thiazolidine-4-one leads to decrease in activity, that may be because of the stearic hindrance caused by the substitution.

![General structure of thiazolidinone derivatives.](IJPhS-70-159-g001){#F0001}

There is tremendous amount of experimental[@CIT13] and theoretical[@CIT14] works, focused on the study of COX-2 and the existence of high-resolution structural information on the binding site of NSAIDs, several aspects of binding mechanism of DUP-697 and related compounds to COX-2 remains unclear. Observing the data from literature[@CIT1]--[@CIT3] reveals that empirical rules formulated for the given set of drugs are not agreeable when applied to a different set, even when both set of compounds share a common background. This suggests that subtle structural changes in binding site of COX-2 might occur to adopt its structure to the inhibitor. This might also be the reason for many diverse group of compounds reported to have antiinflammatory activity[@CIT4]--[@CIT7]. The marketed antiinflammatory drugs contain 2-phenyl rings attached to heterocyclic ring systems like thiophene, oxazolidinone, 1,2-pyrazole and 1,3 pyrazoles with a sulfonyl group and such a combination appears to be essential for specific COX-2 activity[@CIT3][@CIT14]. However, such drugs are also associated with severe adverse effects.

Therefore, from earlier reports and also from our results it can be substantiated that the COX-2 binding site may not be a rigid structure and might adopt to various related groups which may be the reason for thiazolidin-4-one derivatives tested in the present study for having action similar to nimesulide. However substitution at 5-position with spiro moiety resulted in reduced COX-1 and COX-2 inhibitory activity.

In conclusion several derivatives tested in this study showed maximum inhibition of COX-2 activity without inhibiting the COX-1 activity and results are comparable with that of nimesulide. The substitution at particular place i.e., R, R~1~ and R~2~ with the functional groups Cl, OCH~3~, NO~2~ and OH in the aromatic ring resulted in increased activity as compared to unsubstituted thiazolidin-4-ones and substitution at 5-position with spiro group did not improve the activity.
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[^1]: Taranalli, *et al*.: Antiinflammatory, Analgesic and Antipyretic Activity of Thiazolidinones
